Ankit Mahadevia - Net Worth and Insider Trading

Ankit Mahadevia Net Worth

The estimated net worth of Ankit Mahadevia is at least $1 Million dollars as of 2024-05-12. Ankit Mahadevia is the Director of Spero Therapeutics Inc and owns about 744,997 shares of Spero Therapeutics Inc (SPRO) stock worth over $1 Million. Details can be seen in Ankit Mahadevia's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ankit Mahadevia has not made any transactions after 2024-02-02 and currently still holds the listed stock(s).

Transaction Summary of Ankit Mahadevia

To

Ankit Mahadevia Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ankit Mahadevia owns 1 companies in total, including Spero Therapeutics Inc (SPRO) .

Click here to see the complete history of Ankit Mahadevia’s form 4 insider trades.

Insider Ownership Summary of Ankit Mahadevia

Ticker Comapny Transaction Date Type of Owner
SPRO Spero Therapeutics Inc 2024-02-02 director & See Remarks

Ankit Mahadevia Latest Holdings Summary

Ankit Mahadevia currently owns a total of 1 stock. Ankit Mahadevia owns 744,997 shares of Spero Therapeutics Inc (SPRO) as of February 2, 2024, with a value of $1 Million.

Latest Holdings of Ankit Mahadevia

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SPRO Spero Therapeutics Inc 2024-02-02 744,997 1.64 1,221,795

Holding Weightings of Ankit Mahadevia


Ankit Mahadevia Form 4 Trading Tracker

According to the SEC Form 4 filings, Ankit Mahadevia has made a total of 10 transactions in Spero Therapeutics Inc (SPRO) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Spero Therapeutics Inc is the sale of 63,795 shares on February 2, 2024, which brought Ankit Mahadevia around $87,399.

Insider Trading History of Ankit Mahadevia

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ankit Mahadevia Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ankit Mahadevia Ownership Network

Ownership Network List of Ankit Mahadevia

No Data

Ownership Network Relation of Ankit Mahadevia


Ankit Mahadevia Owned Company Details

What does Spero Therapeutics Inc do?

Who are the key executives at Spero Therapeutics Inc?

Ankit Mahadevia is the director & See Remarks of Spero Therapeutics Inc. Other key executives at Spero Therapeutics Inc include Chief Financial Officer Sath Shukla , Chief Medical Officer Kamal Hamed , and Chief Development Officer Timothy Keutzer .

Spero Therapeutics Inc (SPRO) Insider Trades Summary

Over the past 18 months, Ankit Mahadevia made 3 insider transaction in Spero Therapeutics Inc (SPRO) with a net sale of 85,121. Other recent insider transactions involving Spero Therapeutics Inc (SPRO) include a net sale of 91,515 shares made by Sath Shukla , a net sale of 36,219 shares made by Timothy Keutzer , and a net sale of 36,154 shares made by Tamara L Joseph .

In summary, during the past 3 months, insiders sold 0 shares of Spero Therapeutics Inc (SPRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 316,580 shares of Spero Therapeutics Inc (SPRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 316,580 shares.

Spero Therapeutics Inc (SPRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Spero Therapeutics Inc Insider Transactions

No Available Data

Ankit Mahadevia Mailing Address

Above is the net worth, insider trading, and ownership report for Ankit Mahadevia. You might contact Ankit Mahadevia via mailing address: C/o Spero Therapeutics, Inc., 675 Massachusetts Ave., 14th Floor, Cambridge Ma 02139.

Discussions on Ankit Mahadevia

No discussions yet.